Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Onbrez Capsules – Treatment for Chronic Obstructive Pulmonary Disease

The drug received US FDA approval for 75mcg doses in July 2011. It is being marketed under the brand name arcapta in the US.

Go Top